Information about our global response to COVID-19
As we enter unprecedented times in the NHS, wider health and social care services and education, we wanted to say a heartfelt thank you for the exceptionally hard work and commitment you and your colleagues are making to support our society.
Like all of you, we are closely monitoring the impact of COVID-19 (Coronavirus). We are listening to your question and concerns, and, as the situation unfolds, we remain committed to minimising disruption to you and your professional practice.
Pearson’s Clinical Assessment takes the health and safety of our employees, customers, and those you serve very seriously. Our teams are proactively working to provide for the safety of everyone involved with your assessment program and have well-established protocols for mitigating potential disruptions to fulfilling our commitments.
Below you will find information related to Pearson’s Clinical Assessment business and its products. This information will answer some of the most common questions we have fielded concerning our response to the COVID-19 outbreak, including: